Furthermore, the upregulation of the TGF-β signaling pathway in C1, as opposed to C2, suggests that the activation of the TGF-β signaling pathway influences the overall survival of bladder cancer patients. The gene discussed is TGFB1; the disease is urinary bladder cancer.